Liver fibrosis markers, including serum aspartate aminotransferase, alanine aminotransferase and hydroxyproline are attenuated, suggesting that ADP355 is a potent anti-fibrotic agent and potentially an effective intervention against liver fibrosis. The gene discussed is GPT; the disease is Hepatic fibrosis.